Results 91 to 100 of about 21,752 (228)
Journal of the European Academy of Dermatology and Venereology, EarlyView.
S. Benkimoun +14 more
wiley +1 more source
A pathogenic COL7A1 variant highlights semi-dominant inheritance in dystrophic epidermolysis bullosa
BMC Medical GenomicsDystrophic epidermolysis bullosa is a rare subtype of inherited epidermolysis bullosa, caused by variants in the collagen type VII alpha 1 chain (COL7A1) gene (MIM120120).
Saira Sattar +6 more
doaj +1 more source
Hematology, Transfusion and Cell TherapyIntroduction: Secondary thrombocytosis is a well-recognized response to chronic inflammation, infections, and systemic disorders, but its association with dermatologic diseases such as Norwegian scabies and epidermolysis bullosa is rare.
Mine Ezgi Payaslı +3 more
doaj +1 more source
High-Affinity Binding of the NC1 Domain of Collagen VII to Laminin 5 and Collagen IV [PDF]
, 2006 Anchoring functions of collagen VII depend on its ability to form homotypic fibrils and to bind to other macromolecules to form heterotypic complexes. Biosensor-based binding assays were employed to analyze the kinetics of the NC1 domain-mediated binding
Brittingham, Raymond +2 more
core +2 more sources
Пограничный локализованный буллезный эпидермолиз: случай поздней диагностики [PDF]
, 2015 ЭПИДЕРМОЛИЗ БУЛЛЕЗНЫЙ ...
Лесничая, О. В. +2 more
core
The Syk tyrosine kinase is required for skin inflammation in an in vivo mouse model of epidermolysis bullosa acquisita [PDF]
, 2017 The inflammatory form of epidermolysis bullosa acquisita is caused by autoantibodies against type VII collagen (C7), a component of the dermal-epidermal junction.
Mócsai, Attila +3 more
core +1 more source
Real‐World Experience With Oleogel‐S10 for Wounds in Epidermolysis Bullosa
JEADV Clinical PracticeBackground Oleogel‐S10 is the first approved drug for the treatment of wounds in patients with junctional and dystrophic epidermolysis bullosa. Results from the clinical trials, early access programme and open‐label study are available, showing good ...
Miodrag Davidovic +2 more
doaj +1 more source
Lentiviral Engineered Fibroblasts Expressing Codon Optimized COL7A1 Restore Anchoring Fibrils in RDEB [PDF]
, 2016 Cells therapies, engineered to secrete replacement proteins, are being developed to ameliorate otherwise debilitating diseases. Recessive dystrophic epidermolysis bullosa (RDEB) is caused by defects of type VII collagen (C7), a protein essential for ...
Abdul-Wahab, A +15 more
core
The Application of Clinical Genetics, 2021 Sang Trieutien,1,* Tam Vu Van,2,3,* My Tran Ngoc Thao,4 Son Trinh The,5 Khoa Tran Van,1 Tung Nguyen Thanh,5 Tuan Tran Van,5 Hanh Nguyen Thi6 1Department of Biology and Genetics, Vietnam Military Medical University, Hanoi, 12108, Vietnam ...
Trieutien S +7 more
doaj